Table 1.

Reactivity by ELISA and IgM and IgG immunoblot tests after OspA vaccination in 17 individuals participating in phase 2 of the Connaught Lyme vaccine trial

Day after vaccinationa% of samples with:
Positive ELISAPositive IgM immunoblotbPositive IgG immunoblotb
Pre000
30c5300
60d10000
9076Not doneNot done
1803500
  • a See text for details.

  • b Based on CDC/ASTPHLD criteria (3).

  • c Thirty days after receipt of the first 30-μg intramuscular dose of a recombinant OspA vaccine preparation.

  • d Sixty days after receipt of the first 30-μg dose of the recombinant OspA vaccine preparation.